ABIOMED, Inc. (ABMD) Is At $300.28 Formed Wedge; Capital International Investors Lowered By $34.14 Million Its Ameriprise Financial (AMP) Stake

April 11, 2018 - By Jerrie Dane

ABIOMED, Inc. (NASDAQ:ABMD) Logo

Capital International Investors decreased Ameriprise Financial Inc (AMP) stake by 66.64% reported in 2017Q4 SEC filing. Capital International Investors sold 202,000 shares as Ameriprise Financial Inc (AMP)’s stock declined 14.11%. The Capital International Investors holds 101,100 shares with $17.13 million value, down from 303,100 last quarter. Ameriprise Financial Inc now has $21.08 billion valuation. The stock increased 2.06% or $2.91 during the last trading session, reaching $144.29. About 708,757 shares traded. Ameriprise Financial, Inc. (NYSE:AMP) has risen 17.58% since April 11, 2017 and is uptrending. It has outperformed by 6.03% the S&P500.

ABIOMED, Inc. (ABMD) formed wedge up with $318.30 target or 6.00% above today’s $300.28 share price. ABIOMED, Inc. (ABMD) has $13.30B valuation. The stock increased 4.22% or $12.16 during the last trading session, reaching $300.28. About 573,364 shares traded or 29.30% up from the average. ABIOMED, Inc. (NASDAQ:ABMD) has risen 128.67% since April 11, 2017 and is uptrending. It has outperformed by 117.12% the S&P500.

Analysts await ABIOMED, Inc. (NASDAQ:ABMD) to report earnings on May, 3. They expect $0.64 earnings per share, up 93.94% or $0.31 from last year’s $0.33 per share. ABMD’s profit will be $28.34 million for 117.30 P/E if the $0.64 EPS becomes a reality. After $0.70 actual earnings per share reported by ABIOMED, Inc. for the previous quarter, Wall Street now forecasts -8.57% negative EPS growth.

Since February 20, 2018, it had 0 insider purchases, and 1 sale for $5.41 million activity. Shares for $5.41 million were sold by Greenfield Andrew J.

Among 15 analysts covering Abiomed (NASDAQ:ABMD), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Abiomed has $370.0 highest and $80 lowest target. $254.18’s average target is -15.35% below currents $300.28 stock price. Abiomed had 35 analyst reports since August 4, 2015 according to SRatingsIntel. On Thursday, February 1 the stock rating was maintained by Jefferies with “Buy”. Piper Jaffray maintained the stock with “Hold” rating in Wednesday, August 5 report. PiperJaffray upgraded the shares of ABMD in report on Thursday, April 6 to “Overweight” rating. The rating was maintained by Benchmark with “Buy” on Tuesday, August 4. As per Tuesday, August 4, the company rating was maintained by BTIG Research. The firm has “Buy” rating given on Tuesday, August 9 by Jefferies. The firm has “Buy” rating given on Tuesday, June 6 by Jefferies. The stock has “Buy” rating by Guggenheim on Wednesday, December 7. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Monday, April 9 by Stephens. As per Thursday, June 29, the company rating was maintained by Jefferies.

Investors sentiment decreased to 1.18 in 2017 Q4. Its down 0.12, from 1.3 in 2017Q3. It worsened, as 19 investors sold ABIOMED, Inc. shares while 110 reduced holdings. 55 funds opened positions while 97 raised stakes. 36.44 million shares or 5.39% less from 38.51 million shares in 2017Q3 were reported. Louisiana State Employees Retirement System invested in 0.09% or 10,600 shares. Moreover, Cibc Bancshares Usa has 0.04% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 1,550 shares. Eagle Asset Mngmt invested in 0.27% or 259,689 shares. Gideon Cap Advsr Inc invested in 0.2% or 1,222 shares. Regions Finance reported 70 shares. Portolan Limited Com owns 0.46% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 22,440 shares. Moreover, Advisory Net Limited has 0.01% invested in ABIOMED, Inc. (NASDAQ:ABMD). Brown Advisory holds 0% or 8,017 shares in its portfolio. Alliancebernstein Ltd Partnership holds 58,762 shares or 0.01% of its portfolio. Bnp Paribas Asset Management stated it has 0.09% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Ci Invests invested in 25 shares or 0% of the stock. Beaumont Prtnrs Lc holds 0.06% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 2,550 shares. Security National Trust has 400 shares for 0.02% of their portfolio. Moreover, Group One Trading Limited Partnership has 0% invested in ABIOMED, Inc. (NASDAQ:ABMD). 10,872 are owned by Texan Capital.

Capital International Investors increased Alphabet Inc Cl A stake by 900 shares to 275,166 valued at $289.86M in 2017Q4. It also upped Pepsico Inc (NYSE:PEP) stake by 6,302 shares and now owns 1.21M shares. Northrop Grumman Corp (NYSE:NOC) was raised too.

Investors sentiment increased to 1.13 in Q4 2017. Its up 0.16, from 0.97 in 2017Q3. It increased, as 29 investors sold AMP shares while 218 reduced holdings. 81 funds opened positions while 199 raised stakes. 115.74 million shares or 0.30% less from 116.09 million shares in 2017Q3 were reported. Susquehanna Limited Liability Partnership holds 0% or 26,900 shares. Ahl Prns Llp owns 91,897 shares or 0.24% of their US portfolio. Eqis Mgmt holds 2,425 shares or 0.02% of its portfolio. Fort Washington Investment Advsrs Inc Oh stated it has 0.06% of its portfolio in Ameriprise Financial, Inc. (NYSE:AMP). 1,800 are owned by Cordasco Financial Ntwk. Mariner Wealth Advisors Lc reported 1,263 shares stake. Wetherby Asset Incorporated owns 3,898 shares or 0.09% of their US portfolio. Lingohr Partner Asset Mngmt Gmbh has invested 1.51% in Ameriprise Financial, Inc. (NYSE:AMP). Estabrook Mngmt reported 0.05% in Ameriprise Financial, Inc. (NYSE:AMP). Marshall Wace Llp accumulated 21,457 shares or 0.15% of the stock. Dekabank Deutsche Girozentrale has 13,639 shares for 0.02% of their portfolio. Burt Wealth Advsr owns 386 shares. Teachers Insur And Annuity Association Of America owns 41,620 shares or 0.36% of their US portfolio. Rhumbline Advisers has invested 0.1% in Ameriprise Financial, Inc. (NYSE:AMP). Bancorp Of America Corporation De holds 913,273 shares.

Since October 26, 2017, it had 0 insider purchases, and 10 selling transactions for $11.64 million activity. $160,772 worth of Ameriprise Financial, Inc. (NYSE:AMP) was sold by McGraw Deirdre Davey on Thursday, October 26. On Friday, December 8 the insider Sweeney Joseph Edward sold $1.24 million. 4,285 shares valued at $690,271 were sold by MOORE COLIN on Thursday, October 26. $699,256 worth of Ameriprise Financial, Inc. (NYSE:AMP) was sold by Kupper Randy. Another trade for 9,022 shares valued at $1.45 million was made by Woerner John Robert on Thursday, October 26. $5.45M worth of Ameriprise Financial, Inc. (NYSE:AMP) was sold by TRUSCOTT WILLIAM F on Friday, January 26. 1,754 shares were sold by Maglaque Charles Neal, worth $282,412.

Analysts await Ameriprise Financial, Inc. (NYSE:AMP) to report earnings on April, 23. They expect $3.52 earnings per share, up 30.37% or $0.82 from last year’s $2.7 per share. AMP’s profit will be $514.25 million for 10.25 P/E if the $3.52 EPS becomes a reality. After $3.26 actual earnings per share reported by Ameriprise Financial, Inc. for the previous quarter, Wall Street now forecasts 7.98% EPS growth.

ABIOMED, Inc. (NASDAQ:ABMD) Institutional Positions Chart